Literature DB >> 17036382

Management of pseudomyxoma peritonei.

Zhi-Bo Qu1, Lian-Xin Liu.   

Abstract

Pseudomyxoma peritonei (PMP) is a rare disease. It refers to a progressive disease process within the peritoneum which originates from the appendix or ovaries and is characterised by the production of copious amounts of mucinous fluid resulting in a "jelly belly". If untreated the condition is fatal. The traditional approach to PMP is based on repeated surgical debulking procedures, often associated with intraperitoneal or systemic chemotherapy. The natural history of this disease has been drastically modified since the introduction of a new surgical approach defined as a peritonectomy procedure. This paper is to review the literature on this treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036382      PMCID: PMC4088104          DOI: 10.3748/wjg.v12.i38.6124

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Peritonectomy procedures.

Authors:  Paul H Sugarbaker
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

2.  Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma.

Authors:  P H Sugarbaker
Journal:  Eur J Surg Suppl       Date:  1991-05

3.  Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

4.  Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei.

Authors:  Marcello Deraco; Dario Baratti; Maria Grazia Inglese; Biagino Allaria; Salvatore Andreola; Cecilia Gavazzi; Shigeki Kusamura
Journal:  Ann Surg Oncol       Date:  2004-04       Impact factor: 5.344

5.  Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Authors:  Andrew L Feldman; Steven K Libutti; James F Pingpank; David L Bartlett; Tatiana H Beresnev; Sharon M Mavroukakis; Seth M Steinberg; David J Liewehr; David E Kleiner; H Richard Alexander
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

Review 6.  Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei.

Authors:  J Bryant; A J Clegg; M K Sidhu; H Brodin; P Royle; P Davidson
Journal:  Health Technol Assess       Date:  2004-02       Impact factor: 4.014

7.  Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues.

Authors:  G Panteix; M Guillaumont; L Cherpin; J Cuichard; F N Gilly; P Y Carry; A Sayag; B Salle; A Brachet; J Bienvenu
Journal:  Oncology       Date:  1993 Sep-Oct       Impact factor: 2.935

8.  Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case.

Authors:  S Fujimoto; M Takahashi; K Kobayashi; M Kure; H Masaoka; H Ohkubo; S Isaka; J Shimazaki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 9.  Peritoneal carcinomatosis: feature of dissemination. A review.

Authors:  M Deraco; N Santoro; O Carraro; M G Inglese; G Rebuffoni; S Guadagni; D C Somers; M Vaglini
Journal:  Tumori       Date:  1999 Jan-Feb

Review 10.  Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer: guidelines for current practice.

Authors:  A Gomez Portilla; M Deraco; P H Sugarbaker
Journal:  Tumori       Date:  1997 Jul-Aug
View more
  11 in total

1.  Successful pregnancy following transfer of frozen-thawed embryos in a patient with pseudomyxoma peritonei who underwent peritonectomy and bilateral oophorectomy.

Authors:  Ido Laskov; Nadav Michaan; Ariel Many; Ami Amit; Foad Azem
Journal:  J Gynecol Oncol       Date:  2012-04-03       Impact factor: 4.401

2.  Histopathological discrepancy and variation of surgical management in mucinous ovarian cystadenoma and pseudomyxoma peritonei.

Authors:  Gatot Purwoto; Tricia Dewi Anggraeni; Primariadewi Rustamadji; Ilham Utama Surya; Kelli Julianti; Nathaniel Herlambang
Journal:  Int J Surg Case Rep       Date:  2022-05-03

3.  [Systemic treatment of peritoneal metastases].

Authors:  D Arnold; F Lordick
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

4.  Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis.

Authors:  Jung-Wook Huh; Young-Jin Kim; Hyeong-Rok Kim
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 5.  Principles and Innovations in Peritoneal Surface Malignancy Treatment.

Authors:  Kelly M MacArthur; Michael B Nicholl
Journal:  World J Oncol       Date:  2013-07-15

6.  Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review.

Authors:  Yingbo Gong; Xin Wang; Zhi Zhu
Journal:  Gastroenterol Res Pract       Date:  2020-07-03       Impact factor: 2.260

7.  Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei.

Authors:  Lei Liang; Jingyang Fang; Xuedi Han; Xichao Zhai; Yan Song; Yiyan Lu; Qian Zhang; Ruiqing Ma
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

8.  Radiomics analysis based on CT's greater omental caking for predicting pathological grading of pseudomyxoma peritonei.

Authors:  Nan Zhou; Ruixue Dou; Xichao Zhai; Jingyang Fang; Jiajun Wang; Ruiqing Ma; Jingxu Xu; Bin Cui; Lei Liang
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

9.  Aggressive pseudomyxoma peritonei: a case report with an unusual clinical presentation.

Authors:  Zisis Touloumis; George Galyfos; Nikolaos Kavouras; Michalis Menis; Laurant Lavant
Journal:  Case Rep Oncol Med       Date:  2013-11-13

10.  Pseudomyxoma pleurii and peritonei secondary to sigmoid colon adenocarcinoma: a rare clinico-pathologico-radiological presentation.

Authors:  Casmir Wambura; Ahmed Jusabani; Omar Sherman; Salim Surani
Journal:  Oxf Med Case Reports       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.